SEI Investments
ACHN

SEI Investments’s Achillion Pharmaceuticals ACHN Stock Holding History

SEI Investments’s Portfolio ACHN Stock Details ACHN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-56,877
Closed -$393K – 2776
2015
Q3 		$393K Buy
+56,877
New +$463K ﹤0.01% 1374
2015
Q1 		– Sell
-27,089
Closed -$332K – 2411
2014
Q4 		$332K Buy
+27,089
New +$331K ﹤0.01% 1260

Other funds holding ACHN

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

SEI Investments's ACHN Position: Q4 2015 in Review

SEI Investments sold out of Achillion Pharmaceuticals (ACHN) in Q4 2015, closing a stake of 56,877 shares — an estimated $393K sold.

SEI Investments first reported a position in ACHN in Q4 2014 and held it in 2 quarters. The position peaked at $393K in Q3 2015. 152 funds tracked by Wall St. Rank hold ACHN as of Q4 2015.

  • SEI Investments reported no remaining Achillion Pharmaceuticals position as of Q4 2015 after selling out during the quarter.
  • SEI Investments sold 56,877 Achillion Pharmaceuticals shares in Q4 2015, an estimated $393K.
  • SEI Investments first reported a position in Achillion Pharmaceuticals in Q4 2014 and held it in 2 quarters.
  • SEI Investments's Achillion Pharmaceuticals position peaked at $393K in Q3 2015.
  • 152 funds tracked by Wall St. Rank held Achillion Pharmaceuticals as of Q4 2015.

Based on SEI Investments's 13F filing for Q4 2015, filed 3 Feb 2016.